(Q37353934)

19 August 2017

1 reference

title

Chemoradiotherapy and adjuvant chemotherapy for rectal cancer (English)

1 reference

19 August 2017

0 references

1 reference

Toshiaki Watanabe

1

1 reference

19 August 2017

publication date

18 December 2008

1 reference

International Journal of Clinical Oncology

19 August 2017

published in

1 reference

19 August 2017

volume

13

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

488-497

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-008-0849-0

19 August 2017

exact match

0 references

cites work

Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0849-0

Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0849-0

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0849-0

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

21 January 2018

1 reference

12 December 2020

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

12 December 2020

Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?

1 reference

12 December 2020

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).

1 reference

12 December 2020

Mesorectal excision for rectal cancer

1 reference

12 December 2020

Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial

1 reference

12 December 2020

Reduced Survival of Rectal Cancer Patients With Increased Tumor Epidermal Growth Factor Receptor Levels

1 reference

12 December 2020

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

12 December 2020

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

12 December 2020

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

1 reference

12 December 2020

Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

1 reference

12 December 2020

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

12 December 2020

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

12 December 2020

Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC)

1 reference

12 December 2020

Adjuvant therapy of resectable rectal cancer

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group

1 reference

12 December 2020

The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?

1 reference

12 December 2020

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Total mesorectal excision in the operative treatment of carcinoma of the rectum

1 reference

12 December 2020

Indication and benefit of pelvic sidewall dissection for rectal cancer.

1 reference

12 December 2020

Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum--significant improvement of survival rate and decrease of local recurrence

1 reference

12 December 2020

The TME Trial After a Median Follow-up of 6 Years

1 reference

12 December 2020

Adjuvant therapy for rectal cancer--a good first step

1 reference

12 December 2020

The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

1 reference

12 December 2020

Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy

1 reference

12 December 2020

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group

1 reference

12 December 2020

Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial

1 reference

12 December 2020

Preoperative roentgen therapy for cancer of the rectum

1 reference

12 December 2020

Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results

1 reference

12 December 2020

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

1 reference

12 December 2020

Preoperative radiotherapy for colorectal cancer

1 reference

12 December 2020

Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial

1 reference

12 December 2020

Adjuvant radiation therapy for rectal adenocarcinoma

1 reference

12 December 2020

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

1 reference

12 December 2020

The effectiveness of wide anatomical resection and radical lymphadenectomy for patients with rectal cancer

1 reference

12 December 2020

Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial

1 reference

12 December 2020

Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer

1 reference

12 December 2020

Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial

1 reference

12 December 2020

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis

1 reference

12 December 2020

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

1 reference

12 December 2020

The role of radiotherapy in rectal cancer

1 reference

12 December 2020

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators

1 reference

12 December 2020

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

1 reference

12 December 2020

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

1 reference

12 December 2020

Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects

1 reference

12 December 2020

Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation

1 reference

12 December 2020

Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers

1 reference

12 December 2020

Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial

1 reference

12 December 2020

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

Adjuvant therapy for rectal cancer--the transatlantic view

1 reference

12 December 2020

An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.

1 reference

12 December 2020

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

1 reference

12 December 2020

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer

1 reference

12 December 2020

Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group

1 reference

12 December 2020

An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy

1 reference

12 December 2020

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

1 reference

12 December 2020

Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection

1 reference

12 December 2020

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

1 reference

12 December 2020

Radiotherapy additional to surgery in the management of primary rectal carcinoma

1 reference

12 December 2020

Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy

1 reference

12 December 2020

Lymphatic spread and its prognostic value in patients with rectal cancer

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

12 December 2020

Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy

1 reference

12 December 2020

Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome

1 reference

12 December 2020

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials

1 reference

12 December 2020

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

12 December 2020

10.1007/S10147-008-0849-0

Identifiers

DOI

1 reference

19 August 2017

1 reference